NMDA receptor involvement in two animal models of Parkinson's disease
Authors:
- William J. NicklasWNWilliam J. Nicklas
- Patricia K. SonsallaPSPatricia K. Sonsalla
- 30 April 1994
- journal article
- review article
- Published by Elsevier in Neurobiology of Aging
- Vol. 15 (2) , 269-270
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- MK‐801 Prevents 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Parkinsonism in PrimatesJournal of Neurochemistry, 1992
- 1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative MetabolismJournal of Neurochemistry, 1992
- MK‐801 Fails to Protect Against the Dopaminergic Neuropathology Produced by Systemic 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mice or Intranigral 1‐Methyl‐4‐Phenylpyridinium in RatsJournal of Neurochemistry, 1992
- Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonistsNature, 1991
- The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal DeathAnnual Review of Neuroscience, 1990
- Abnormalities of the electron transport chain in idiopathic parkinson's diseaseAnnals of Neurology, 1989
- Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic ToxicityScience, 1989
- Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicityNeuroscience Letters, 1985
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineLife Sciences, 1985